This comparison examines Alcon Inc. (ALC) and IQVIA Holdings Inc. (IQV), two healthcare-focused companies with distinct business models. ALC specializes in eye care products and surgical solutions, while IQV delivers data analytics, clinical research services, and technology platforms primarily to pharmaceutical and biotech firms. The analysis targets traders and investors seeking to understand relative performance, sector exposures, and recent developments in a dynamic market environment. It provides objective insights into business contexts, momentum factors, and positioning without offering recommendations.
Alcon Inc. (ALC) is a global leader in eye care, offering surgical equipment, intraocular lenses, and vision care products including contact lenses and pharmaceuticals. The company serves ophthalmologists, optometrists, and consumers worldwide through its surgical and vision care segments. In recent market activity, ALC shares experienced modest fluctuations amid broader healthcare sector movements and specific analyst commentary on competitive pressures and softer demand in certain product lines. Recent weeks reflected ongoing innovation efforts, such as collaborations on advanced lens technologies, alongside some downward adjustments to price targets by research firms. Sentiment has been shaped by execution on new product launches and overall industry demand for vision correction solutions, with the stock trading within a range influenced by macroeconomic factors affecting elective procedures.
IQVIA Holdings Inc. (IQV) is a leading provider of clinical research services, healthcare analytics, and technology solutions to the life sciences sector. It supports drug development, commercialization, and real-world evidence generation for pharmaceutical, biotechnology, and medical device companies. Recent market activity for IQV featured positive responses to quarterly results that exceeded expectations, including revenue growth and raised full-year guidance. In recent weeks, the stock showed upward momentum following these developments, with multiple analyst firms increasing price targets. Sentiment benefited from strong bookings trends, demand for clinical trial services, and the company’s positioning in data-driven healthcare outsourcing. Broader influences included sustained investment in research and development across the pharmaceutical industry.
Tickeron’s Trending AI Robots page showcases a curated selection of high-performing AI trading bots drawn from a platform offering hundreds of automated strategies. These bots trade thousands of different tickers using varied approaches, timeframes, and risk parameters tailored to evolving market conditions. Only the most suitable and effective bots, based on backtested performance metrics, win rates, and adaptability, earn placement in this trending section. Available bots display a wide range of statistics, including historical returns, drawdowns, and trade frequencies, allowing users to explore options suited to different styles such as momentum, mean-reversion, or sector-specific tactics. The platform emphasizes diversity in strategies and ticker coverage to support varied trading objectives. For more details on current trending options, visit Trending AI Robots.
Alcon Inc. (ALC) and IQVIA Holdings Inc. (IQV) operate in adjacent but distinct areas of healthcare. ALC focuses on product manufacturing and sales in vision care, exposing it to consumer and procedural demand cycles, whereas IQV emphasizes service-based outsourcing and data analytics, benefiting from pharmaceutical research and development spending. Recent momentum favored IQV following earnings beats and guidance increases, while ALC navigated mixed analyst reactions and competitive factors. Growth drivers for ALC include new lens technologies and global vision health needs; for IQV, they center on clinical trial volume and analytics adoption. Risk considerations encompass regulatory approvals and reimbursement for ALC versus client retention and operational leverage for IQV. Sector sentiment reflects healthcare resilience, though relative positioning varies with earnings visibility and innovation pipelines.
Based on observable factors such as recent earnings consistency, guidance revisions, and analyst sentiment shifts, Tickeron’s AI would currently assign a higher probability of relative outperformance to IQVIA Holdings Inc. (IQV) over Alcon Inc. (ALC). Stronger momentum in bookings and raised outlook metrics provide clearer near-term catalysts for IQV, while ALC faces more variable sentiment around product-specific demand. This assessment reflects probabilistic evaluation of trend stability and positioning rather than guarantees of future results.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green whileIQV’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 5 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).
ALC (@Pharmaceuticals: Other) experienced а +4.27% price change this week, while IQV (@Medical Specialties) price change was +2.40% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.64%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was +6.67%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +0.16%. For the same industry, the average monthly price growth was +8.65%, and the average quarterly price growth was +24.78%.
ALC is expected to report earnings on Nov 10, 2026.
IQV is expected to report earnings on Nov 04, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (+0.16% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| ALC | IQV | ALC / IQV | |
| Capitalization | 35.3B | 39.8B | 89% |
| EBITDA | 2.54B | 3.53B | 72% |
| Gain YTD | -6.636 | 7.231 | -92% |
| P/E Ratio | 56.17 | 30.06 | 187% |
| Revenue | 10.6B | 17B | 62% |
| Total Cash | 1.66B | 2.08B | 80% |
| Total Debt | 5.25B | 16.2B | 32% |
ALC | IQV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 80 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | 67 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | 100 | |
SMR RATING 1..100 | 88 | 42 | |
PRICE GROWTH RATING 1..100 | 48 | 6 | |
P/E GROWTH RATING 1..100 | 17 | 36 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALC's Valuation (38) in the Hospital Or Nursing Management industry is in the same range as IQV (67) in the Servicestothe Health Industry industry. This means that ALC’s stock grew similarly to IQV’s over the last 12 months.
ALC's Profit vs Risk Rating (91) in the Hospital Or Nursing Management industry is in the same range as IQV (100) in the Servicestothe Health Industry industry. This means that ALC’s stock grew similarly to IQV’s over the last 12 months.
IQV's SMR Rating (42) in the Servicestothe Health Industry industry is somewhat better than the same rating for ALC (88) in the Hospital Or Nursing Management industry. This means that IQV’s stock grew somewhat faster than ALC’s over the last 12 months.
IQV's Price Growth Rating (6) in the Servicestothe Health Industry industry is somewhat better than the same rating for ALC (48) in the Hospital Or Nursing Management industry. This means that IQV’s stock grew somewhat faster than ALC’s over the last 12 months.
ALC's P/E Growth Rating (17) in the Hospital Or Nursing Management industry is in the same range as IQV (36) in the Servicestothe Health Industry industry. This means that ALC’s stock grew similarly to IQV’s over the last 12 months.
| ALC | IQV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 62% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 53% | 1 day ago 64% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 73% |
| MACD ODDS (%) | 1 day ago 56% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 58% | 1 day ago 62% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 66% |
| Advances ODDS (%) | 3 days ago 57% | 3 days ago 60% |
| Declines ODDS (%) | 8 days ago 55% | 10 days ago 66% |
| BollingerBands ODDS (%) | 1 day ago 62% | 1 day ago 53% |
| Aroon ODDS (%) | 1 day ago 40% | 1 day ago 53% |
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.
| Ticker / NAME | Correlation To IQV | 1D Price Change % | ||
|---|---|---|---|---|
| IQV | 100% | -0.87% | ||
| CRL - IQV | 72% Closely correlated | +0.84% | ||
| TMO - IQV | 69% Closely correlated | -0.33% | ||
| MEDP - IQV | 65% Loosely correlated | -1.41% | ||
| RVTY - IQV | 62% Loosely correlated | +1.86% | ||
| A - IQV | 60% Loosely correlated | -0.84% | ||
More | ||||